Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA intercalation refers to the process by which certain molecules, typically small, planar, aromatic compounds known as intercalators, insert themselves between adjacent base pairs of the DNA double helix. This non-covalent binding mode alters the structure and function of DNA and is a key mechanism for several classes of drugs and molecular probes.
Intercalation disrupts normal biological processes involving DNA. Inhibits replication and transcription by physically blocking polymerases or altering local helical structure. Can modulate gene expression through effects on transcription factor binding or chromatin architecture. Some intercalators act indirectly by affecting enzymes such as topoisomerases involved in maintaining DNA topology
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic Acid (Intercalation) (DNA (Intercalation)).